This Biogen Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Avi Kapoor 4 months ago
Trading IdeasPre-Market OutlookNewsAnalyst RatingsUpgrades
Top Wall Street analysts changed their outlook on top names. Upgrade on NIO, COF, KEYS, BIIB, and AXP, see other ratings and consider buying BIIB.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Goldman Sachs analyst Tina Hou upgraded Nio Inc – ADR (NYSE:NIO) from Neutral to Buy and announced a $7 price target. Nio shares closed at $4.78 on Friday. See how other analysts view this stock.
- HSBC analyst Saul Martinez upgraded Capital One Financial Corp (NYSE:COF) from Hold to Buy and raised the price target from $226 to $229. Capital One Financial shares closed at $201.52 on Friday. See how other analysts view this stock.
- Morgan Stanley analyst Meta Marshall upgraded Keysight Technologies Inc (NYSE:KEYS) from Equal-Weight to Overweight and raised the price target from $350 to $400. Keysight shares closed at $322.05 on Friday. See how other analysts view this stock.
- Truist Securities analyst Srikripa Devarakonda upgraded Biogen Inc (NASDAQ:BIIB) from Hold to Buy and boosted the price target from $190 to $235. Biogen shares closed at $199.15 on Friday. See how other analysts view this stock.
- JP Morgan analyst Richard Shane upgraded American Express Co (NYSE:AXP) from Neutral to Overweight and raised the price target from $328 to $400. American Express shares closed at $350.58 on Friday. See how other analysts view this stock.
Considering buying BIIB stock? Here’s what analysts think:
Photo via Shutterstock